Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 16 | 2026 | 296 | 6.330 |
Why?
|
| Nanomedicine | 6 | 2024 | 62 | 2.090 |
Why?
|
| Drug Delivery Systems | 3 | 2024 | 236 | 1.500 |
Why?
|
| Polysaccharides | 3 | 2026 | 70 | 1.270 |
Why?
|
| Metal Nanoparticles | 4 | 2022 | 137 | 1.050 |
Why?
|
| Endosomes | 1 | 2026 | 57 | 0.950 |
Why?
|
| Lipids | 2 | 2026 | 224 | 0.890 |
Why?
|
| Kupffer Cells | 1 | 2024 | 11 | 0.830 |
Why?
|
| RNA, Messenger | 1 | 2026 | 673 | 0.820 |
Why?
|
| Liver Diseases | 1 | 2024 | 52 | 0.810 |
Why?
|
| Liver | 2 | 2024 | 497 | 0.770 |
Why?
|
| Transcytosis | 1 | 2023 | 4 | 0.770 |
Why?
|
| Protein Corona | 2 | 2022 | 9 | 0.740 |
Why?
|
| Endothelial Cells | 1 | 2024 | 377 | 0.640 |
Why?
|
| Endothelium, Vascular | 1 | 2023 | 359 | 0.610 |
Why?
|
| Disaccharides | 3 | 2026 | 25 | 0.600 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 488 | 0.560 |
Why?
|
| Brain | 1 | 2023 | 774 | 0.510 |
Why?
|
| Liposomes | 4 | 2026 | 149 | 0.490 |
Why?
|
| Polyethylene Glycols | 2 | 2026 | 105 | 0.400 |
Why?
|
| Humans | 16 | 2026 | 29295 | 0.380 |
Why?
|
| Animals | 12 | 2026 | 10835 | 0.350 |
Why?
|
| Spectrum Analysis | 2 | 2022 | 33 | 0.350 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 200 | 0.320 |
Why?
|
| Endocytosis | 2 | 2022 | 97 | 0.320 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 610 | 0.310 |
Why?
|
| Kinetics | 2 | 2021 | 553 | 0.290 |
Why?
|
| Nanostructures | 2 | 2018 | 64 | 0.240 |
Why?
|
| Surface Properties | 1 | 2026 | 139 | 0.240 |
Why?
|
| Phagocytosis | 1 | 2024 | 81 | 0.200 |
Why?
|
| Point-of-Care Systems | 1 | 2024 | 22 | 0.200 |
Why?
|
| Mice | 5 | 2026 | 4891 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 116 | 0.200 |
Why?
|
| Polymers | 2 | 2022 | 118 | 0.200 |
Why?
|
| Clathrin | 1 | 2022 | 20 | 0.180 |
Why?
|
| Gold | 5 | 2022 | 137 | 0.180 |
Why?
|
| Adsorption | 1 | 2022 | 34 | 0.180 |
Why?
|
| Silver | 1 | 2022 | 21 | 0.180 |
Why?
|
| Blood Proteins | 1 | 2022 | 68 | 0.170 |
Why?
|
| Neoplasms | 2 | 2022 | 890 | 0.170 |
Why?
|
| Nanotubes | 1 | 2021 | 15 | 0.170 |
Why?
|
| Bioprinting | 1 | 2021 | 9 | 0.170 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 206 | 0.170 |
Why?
|
| Female | 4 | 2026 | 15883 | 0.170 |
Why?
|
| Machine Learning | 1 | 2022 | 98 | 0.170 |
Why?
|
| Glioblastoma | 1 | 2022 | 110 | 0.160 |
Why?
|
| Proteins | 2 | 2022 | 256 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2022 | 237 | 0.150 |
Why?
|
| Hepatobiliary Elimination | 1 | 2019 | 1 | 0.150 |
Why?
|
| Biodegradable Plastics | 1 | 2019 | 2 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 70 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 303 | 0.140 |
Why?
|
| Biological Transport | 1 | 2019 | 128 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 315 | 0.140 |
Why?
|
| Trastuzumab | 1 | 2018 | 12 | 0.140 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 42 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2018 | 82 | 0.130 |
Why?
|
| Aging | 1 | 2024 | 1043 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 130 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 1365 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 31 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2022 | 137 | 0.050 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2022 | 32 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 83 | 0.040 |
Why?
|
| Mechanical Phenomena | 1 | 2022 | 21 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2021 | 12 | 0.040 |
Why?
|
| Gelatin | 1 | 2021 | 11 | 0.040 |
Why?
|
| Axons | 1 | 2021 | 30 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 117 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2021 | 31 | 0.040 |
Why?
|
| Hydrogels | 1 | 2021 | 60 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 325 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 89 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 378 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 105 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2021 | 152 | 0.040 |
Why?
|
| Editorial Policies | 1 | 2019 | 7 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2019 | 20 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 198 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2019 | 6 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 430 | 0.040 |
Why?
|
| Algorithms | 1 | 2022 | 434 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 53 | 0.040 |
Why?
|
| Research | 1 | 2019 | 93 | 0.040 |
Why?
|
| Particle Size | 1 | 2018 | 105 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2019 | 97 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 58 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 43 | 0.030 |
Why?
|
| Intestines | 1 | 2019 | 121 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 1596 | 0.030 |
Why?
|
| Carbon | 1 | 2018 | 107 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 180 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2018 | 119 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 795 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2016 | 13 | 0.030 |
Why?
|
| Optics and Photonics | 1 | 2016 | 24 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 829 | 0.030 |
Why?
|